Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reinhard Kelsch

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Plos One|January 7, 2014
Syndecan-1 (CD138) modulates triple-negative breast cancer stem cell properties via regulation of LRP-6 and IL-6-mediated STAT3 signalingSherif A Ibrahim, Hebatallah Hassan, Laura Vilardo, et al.
HLA|December 24, 2021
Determination of unacceptable HLA antigen mismatches in kidney transplant recipientsMalte Ziemann, Barbara Suwelack, Bernhard Banas, et al.
Carcinogenesis|January 8, 2009
Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progressionViktoriya Nikolova, Chuay-Yeng Koo, Sherif Abdelaziz Ibrahim, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 25, 2017
Unacceptable human leucocyte antigens for organ offers in the era of organ shortage: influence on waiting time before kidney transplantationMalte Ziemann, Nicole Heßler, Inke R König, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 4, 2018
Relative Impact of HLA Matching and Non-HLA Donor Characteristics on Outcomes of Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic SyndromeFrancis Ayuk, Dietrich W Beelen, Martin Bornhäuser, et al.
Frontiers in Immunology|June 25, 2026
Risk-adapted HLA delisting and imlifidase-enabled deceased-donor kidney transplantation in highly sensitized kidney transplant candidates: a German expert consensus reportStefan Reuter, Louise Benning, Andrea Dick, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Plos One|January 7, 2014
Syndecan-1 (CD138) modulates triple-negative breast cancer stem cell properties via regulation of LRP-6 and IL-6-mediated STAT3 signalingSherif A Ibrahim, Hebatallah Hassan, Laura Vilardo, et al.
HLA|December 24, 2021
Determination of unacceptable HLA antigen mismatches in kidney transplant recipientsMalte Ziemann, Barbara Suwelack, Bernhard Banas, et al.
Carcinogenesis|January 8, 2009
Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progressionViktoriya Nikolova, Chuay-Yeng Koo, Sherif Abdelaziz Ibrahim, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 25, 2017
Unacceptable human leucocyte antigens for organ offers in the era of organ shortage: influence on waiting time before kidney transplantationMalte Ziemann, Nicole Heßler, Inke R König, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 4, 2018
Relative Impact of HLA Matching and Non-HLA Donor Characteristics on Outcomes of Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic SyndromeFrancis Ayuk, Dietrich W Beelen, Martin Bornhäuser, et al.
Frontiers in Immunology|June 25, 2026
Risk-adapted HLA delisting and imlifidase-enabled deceased-donor kidney transplantation in highly sensitized kidney transplant candidates: a German expert consensus reportStefan Reuter, Louise Benning, Andrea Dick, et al.
Pageof 3